)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Sumitomo Chemical Company
Sumitomo Chemical Company (4005) investor relations material
Sumitomo Chemical Company Q2 2027 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2027 earnings summary2 Nov, 2026
Executive summary
H1 FY2026 core operating income rose to ¥144.5B from ¥108.7B and attributable net income to ¥82.9B from ¥39.7B; both exceeded the August forecast, with results ranking second-highest on record.
Higher equity-method income, semiconductor-material shipments, petrochemical improvement and temporary inventory valuation gains supported results.
Financial highlights
Sales revenue was ¥1,172.8B, up ¥77.4B or 7.1% YoY; operating income was ¥138.1B, up ¥34.4B or 33.2%.
Core operating income was ¥144.5B, up ¥35.8B; equity-method investment income was ¥36.7B versus a ¥27.3B loss YoY.
Net income was ¥105.7B versus ¥90.9B; attributable net income was ¥82.9B versus ¥39.7B, up 108.8%.
Income before taxes rose 38.7% to ¥121.9B; tax expense was ¥16.3B versus a ¥3.0B tax benefit in the prior-year period.
Revenue gains from selling prices (+¥84B) and FX (+¥58.1B) were partly offset by volume (-¥64.7B); non-recurring items were a ¥6.5B loss.
Outlook and guidance
FY2026 forecasts: revenue ¥2,490B, core operating income ¥270B, operating income ¥215B and attributable net income ¥90B; revisions were +¥130B, +¥55B, +¥38B and +¥20B, respectively.
Excluding business-sale gains, core operating income is forecast at ~¥260B; forecast excludes the timing difference in the FY2025 partial Petro Rabigh share sale.
FY2026 assumptions: USD/JPY 150 for H2 and 157 for the full year; naphtha ¥99,000/kL for the full year. ROE is forecast at 8.6%.
Core operating income forecasts rose to ¥60B for ICT & Mobility, ¥75B for Essential & Green Materials and ¥108B for Sumitomo Pharma; Agro & Life Solutions was unchanged.
Annual dividend guidance rose to ¥17/share, including ¥8 interim and ¥9 year-end; the prior ¥24/share record remains an objective subject to performance and uncertainty.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Sumitomo Chemical Company
- Core operating income and net income soared, with strong outlook despite market uncertainties.4005
Q1 2027 - Core operating income and net income rose sharply, with FY2026 set for further growth.4005Q4 2026
- Profits soared year-over-year, prompting upward revisions to forecasts and dividends.4005Q3 2026
- Profitability rebounded sharply, driven by pharma gains, asset sales, and improved margins.4005Q2 2026
- Core operating income rose sharply despite lower sales and FX losses; outlook is positive.4005Q1 2026
- V-shaped profit recovery and portfolio restructuring drive improved FY2024 outlook.4005Q2 2025
- Targets JPY 200B core income by 2027 and JPY 350B by 2035, led by Agro and ICT growth.4005Status Update
- FY2024 saw a sharp profit rebound and improved cash flow, with higher dividends ahead.4005Q4 2025
- Q3 FY2024 delivered a strong profit rebound and segment growth, with guidance maintained.4005Q3 2025
Next Sumitomo Chemical Company earnings date
Q3 20272 Feb, 2027
Sumitomo Chemical Company
Next Sumitomo Chemical Company earnings date
Q3 20272 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Sumitomo Chemical Company Limited is a Japanese chemical company that manufactures a wide range of products for industrial and consumer use. Its business segments include petrochemicals, energy and functional materials, IT-related chemicals, health and crop sciences, and pharmaceuticals. The company provides materials used in various industries, such as plastics, electronics, agriculture, and healthcare. The company is headquartered in Tokyo, Japan, and its shares are listed on the Tokyo Stock Exchange (TSE).